Human Lymphocyte Antigen Reactivity Modified by Neuraminidase
Emily A. Grothaus 1,
M. Wayne Flye 2,
Emund Yunis 3, and
D. B. Amos 4
1 Division of Immunology, Duke Medical Center, Durham, North Carolina 27706
2 Department of Surgery and Division of Immunology, Duke Medical Center
3 Blood Bank and Department of Immunology, University of Minnesota, Minneapolis 55455
4 Division of Immunology, Duke Medical Center
Human lymphocytes treated with neuraminidase (from Vibrio cholera) are more susceptible to lysis with antiserums directed against HL-A antigens in the cytotoxicity test than are the corresponding cells incubated in buffer. Enzymetreated cells are also lysed by antibodies other than those directed against HL-A, but control cells are not. The extra sensitivity to antibody disappears after 2 to 6 days in tissue culture.